A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
NCT ID: NCT01347710
Last Updated: 2020-11-24
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
795 participants
INTERVENTIONAL
2011-06-30
2013-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Flurpiridaz F18
Open-label study of a single dose of Flurpiridaz F18 injection for PET MPI compared to a single dose of 99mTc sestamibi or tetrofosmin for SPECT MPI in patients with suspected or known coronary artery disease referred for coronary catheterization
Flurpiridaz F18
Injection of Flurpiridaz F18 for the purposes of PET myocardial profusion imaging (MPI) analysis
99mTechnicium (sestamibi or tetrofosmin)
Injection of 99mTc sestamibi or tetrofosmin for the purposes of SPECT MPI analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Flurpiridaz F18
Injection of Flurpiridaz F18 for the purposes of PET myocardial profusion imaging (MPI) analysis
99mTechnicium (sestamibi or tetrofosmin)
Injection of 99mTc sestamibi or tetrofosmin for the purposes of SPECT MPI analysis
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
Unstable cardiac status. History of coronary artery bypass graft. History of percutaneous coronary intervention within the past six months. See protocol for additional details.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lantheus Medical Imaging
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cesare Orlandi, MD
Role: STUDY_DIRECTOR
Lantheus Medical Imaging
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology Associates of Mobile, Inc.
Mobile, Alabama, United States
Scottsdale Medical Imaging, Ltd.
Scottsdale, Arizona, United States
West Side Medical Associates of Los Angeles
Beverly Hills, California, United States
USC PET Imaging Science Center
Los Angeles, California, United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
VA West Los Angeles Medical Center
Los Angeles, California, United States
UCLA
Los Angeles, California, United States
Veterans Affairs Palo Alto Health Care System
Palo Alto, California, United States
Cardiovascular Consultants Medical Group
Pleasant Hill, California, United States
Northern California PET Imaging Center-Palo Alto
Sacramento, California, United States
VA San Diego Healthcare System
San Diego, California, United States
UCSF Medical Center
San Francisco, California, United States
Yale University
New Haven, Connecticut, United States
Alfieri Cardiology
Newark, Delaware, United States
Christiana Care Health System
Newark, Delaware, United States
Elite Research and Clinical Trials
Aventura, Florida, United States
Independent Imaging, LLC
Boynton Beach, Florida, United States
Coastal Cardiology Consultants dba The Heart & Vascular Institute of Florida
Clearwater, Florida, United States
Florida Heart Associates
Fort Myers, Florida, United States
St. Luke's Cardiology Associates
Jacksonville, Florida, United States
The Cardiovascular Center, PA
Lake Mary, Florida, United States
Florida Hospital/Cardiovascular Institute (Florida Heart Group)
Orlando, Florida, United States
South Florida Research Solutions
Pembroke Pines, Florida, United States
Memorial Hospital of Tampa
Tampa, Florida, United States
Georgia Health Sciences Univ/Med College of GA
Augusta, Georgia, United States
South Coast Imaging Center
Savannah, Georgia, United States
Gateway Cardiology, PC
Jerseyville, Illinois, United States
Norton Cardiovascular Associates
Louisville, Kentucky, United States
Biomedical Research Foundation of Northwest Louisiana
Shreveport, Louisiana, United States
Maine Research Associates
Auburn, Maine, United States
Johns Hopkins University
Baltimore, Maryland, United States
Mass General Hospital (MGH)
Boston, Massachusetts, United States
Boston University Medical Center
Boston, Massachusetts, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Wayne State University - Harper University Hospital
Detroit, Michigan, United States
Henry Ford Hospital
Detroit, Michigan, United States
St. Mary's Healthcare (Trinity Health)
Grand Rapids, Michigan, United States
McLaren Macomb
Mount Clemens, Michigan, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Hattiesburg Clinic
Hattiesburg, Mississippi, United States
Missouri Cardiovascular Specialists, LLP
Columbia, Missouri, United States
Cardiovascular Imaging Technologies (CVIT)
Kansas City, Missouri, United States
Saint Louis University School of Medicine
St Louis, Missouri, United States
Washington University School of Medicine
St Louis, Missouri, United States
Las Vegas Radiology
Las Vegas, Nevada, United States
Mount Sinai Medical Center
New York, New York, United States
Columbia University Medical Center
New York, New York, United States
St. Francis Hospital
Roslyn, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
University of Cincinnati
Cincinnati, Ohio, United States
The Ohio State University
Columbus, Ohio, United States
OhioHealth Research Institute
Columbus, Ohio, United States
Kettering Medical Center
Kettering, Ohio, United States
Pinnacle Health Cardiovascular Institute/ Associated Cardiologists
Harrisburg, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Presbyterian University Hospital
Pittsburgh, Pennsylvania, United States
Berks Cardiologists, Ltd.
Wyomissing, Pennsylvania, United States
York Hospital /Wellspan Health
York, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Wellmont CVA Heart Institute
Kingsport, Tennessee, United States
Center for Biomedical Research
Knoxville, Tennessee, United States
Cardiovascular Research of Knoxville - St. Mary's Health Care System, Inc.
Knoxville, Tennessee, United States
Vanderbilt Heart and Vascular Institute
Nashville, Tennessee, United States
Dallas VA Medical Center
Dallas, Texas, United States
University of Texas Medical Branch
Galveston, Texas, United States
Excel Diagnostics and Nuclear Oncology Center
Houston, Texas, United States
Katy Cardiology
Katy, Texas, United States
West Houston Area Clinical Trial Consultants, LLC
Tomball, Texas, United States
University of Virginia Health System
Charlottesville, Virginia, United States
McGuire Veteran Affairs Medical Center
Richmond, Virginia, United States
Carilion Cardiology Clinic
Roanoke, Virginia, United States
Roanoke Heart Institute
Roanoke, Virginia, United States
University of Western Ontario
London, Ontario, Canada
KMH Cardiology and Diagnostic and MRI Centres
Mississauga, Ontario, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Centre Hospitalier Universitaire de Sherbrooke (CHUS)
Sherbrooke, Quebec, Canada
Helsinki University Hospital
Helsinki, , Finland
Turku PET Centre
Turku, , Finland
San Patricio MEDFLIX (San Patricio MRI & CT Center)
Guaynabo, , Puerto Rico
VA Caribbean Healthcare System
San Juan, , Puerto Rico
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lopez DM, Huck D, Divakaran S, Brown JM, Weber B, Lemley M, Builoff V, Shanbhag A, Lan Z, Buckley C, Al-Mallah MH, Dorbala S, Blankstein R, Slomka P, Di Carli MF. Utility of 18F-Flurpiridaz PET Relative Flow Reserve in Differentiating Obstructive From Nonobstructive Coronary Artery Disease. Circ Cardiovasc Imaging. 2025 Oct 9:e018323. doi: 10.1161/CIRCIMAGING.125.018323. Online ahead of print.
Poitrasson-Riviere A, Moody JB, Renaud JM, Hagio T, Arida-Moody L, Buckley CJ, Al-Mallah MH, Nallamothu BK, Weinberg RL, Ficaro EP, Murthy VL. Integrated myocardial flow reserve (iMFR) assessment: optimized PET blood flow quantification for diagnosis of coronary artery disease. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):136-146. doi: 10.1007/s00259-023-06455-2. Epub 2023 Oct 9.
Hagio T, Moody JB, Poitrasson-Riviere A, Renaud JM, Pierce L, Buckley C, Ficaro EP, Murthy VL. Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1028-1033. doi: 10.1007/s00259-022-06045-8. Epub 2022 Nov 19.
Maddahi J, Lazewatsky J, Udelson JE, Berman DS, Beanlands RSB, Heller GV, Bateman TM, Knuuti J, Orlandi C. Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease. J Am Coll Cardiol. 2020 Jul 28;76(4):391-401. doi: 10.1016/j.jacc.2020.05.063.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BMS747158-301
Identifier Type: -
Identifier Source: org_study_id